According to FutureWise analysis the market for toxoplasmosis treatment in 2023 is US$ 0.75 billion, and is expected to reach US$ 1.11 billion by 2031 at a CAGR of 5.00%.
Toxoplasmosis, a zoonotic disease caused by the parasite toxoplasma bendy in humans, can cause a variety of clinical syndromes. Toxoplasmosis can be life-threatening, severe, and even fatal. Toxoplasmosis has been classified by the Centers for Disease Control and Prevention as one of five neglected parasitic infections. Although toxoplasmosis can affect many people, only a few may be affected by serious complications. Most patients experience flu-like symptoms until the parasite can be controlled by their immune system. However, the organism can be reactivated by people with compromised immunity. Active infection can also cause blindness, encephalitis, or other complications such as brain inflammation and death.
Toxoplasma gondii is a single-celled parasite that causes toxins. It can be found in cat feces as well as undercooked meats, such as lamb, venison, and pork. It can also be transmitted by unpasteurized goat milk and contaminated water. Rare cases of transmission from mother to child and during organ transplantation are possible. Blood tests are used to diagnose toxoplasmosis. Two types of antibodies can be detected by laboratory tests. The first antibody is an immune agent that is present in the body during active parasite infection. If you have had an infection in the past, another antibody may be present. Your healthcare provider might repeat the test after two weeks depending on the results. Depending on your symptoms and health, more diagnostic tests may be used.
Toxoplasmosis can cause flu-like symptoms, such as body aches and pains that can last up to a month. Toxoplasmosis may cause serious brain, eye, or other organ damage. Patients with compromised immune systems, HIV-positive/AIDS patients, chemotherapy patients, and pregnant women are more at risk for toxoplasmosis. There are four types: acute toxoplasmosis (CNS), congenital toxoplasmosis, and congenital toxoplasmosis. Acute toxoplasmosis can be symptomless and causes mild flu-like symptoms like fever and myalgia. CNS toxoplasmosis is a common infection in patients with AIDS and other immunocompromised patients. Congenital toxoplasmosis can be an asymptomatic condition that a mother may have contracted during pregnancy. Reactivated congenital diseases can cause ocular toxoplasmosis, which causes blurred vision and sometimes blindness. Toxoplasmosis is diagnosed by serological testing, CT and MRI scans as well as lumbar puncture, biopsy, and PCR. CNS toxoplasmosis is diagnosed by MRI and CT scans. Contrast agents and laboratory tests are also available. Toxoplasmosis patients are given pyrimethamine or sulphadiazine. Pregnant women who have been infected by the disease are given spiramycin, pyrimethamine, or sulphadiazine.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Toxoplasmosis Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Toxoplasmosis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.